Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia by Yimer, Solomon Abebe et al.
Yimer et al. BMC Infectious Diseases 2014, 14:19
http://www.biomedcentral.com/1471-2334/14/19RESEARCH ARTICLE Open AccessTime to first consultation, diagnosis and
treatment of TB among patients attending a
referral hospital in Northwest, Ethiopia
Solomon A Yimer1,2,3,4*, Gunnar A Bjune2 and Carol Holm-Hansen1Abstract
Background: Early detection and treatment of TB is essential for the success of TB control program performance.
The aim of this study was to determine the length and analyze predictors of patients’, health systems’ and total
delays among patients attending a referral hospital in Bahir Dar, Ethiopia.
Methods: A cross-sectional study was conducted among newly diagnosed TB cases ≥ 15 years of age. Delay was
analyzed at three levels: the periods between 1) onset of TB symptoms and first visit to medical provider, i.e.
patients’ delay, 2) the first visit to a medical provider and the initiation of treatment i.e. health systems’ delay and 3)
onset of TB symptoms and initiation of treatment i.e. total delay. Uni- and multi-variate logistic regression analyses
were performed to investigate predictors of patients’, health systems’ and total delays.
Results: The median time of patients’ delay was 21 days [(interquartile range (IQR) (7 days, 60 days)]. The median health
systems’ delay was 27 days (IQR 8 days, 60 days) and the median total delay was 60 days (IQR 30 days, 121 days).
Patients residing in rural areas had a three-fold increase in patients’ delay compared to those from urban areas [Adjusted
Odds Ratio (AOR) 3.4; 95% (CI 1.3, 8.9)]. Extra-pulmonary TB (EPTB) cases were more likely to experience delay in seeking
treatment compared to pulmonary (PTB) cases [(AOR 2.6; 95% (CI 1.3, 5.4)]. Study subjects who first visited health centres
[(AOR) 5.1; 95% (CI 2.1, 12.5)], private facilities [(AOR) 3.5; 95% (CI 1.3, 9.7] and health posts [(AOR) 109; 95% (CI 12, 958],
were more likely to experience an increase in health systems’ delay compared to those who visited hospitals.
Conclusions: The majority of TB patients reported to medical providers within an acceptable time after the onset of
symptoms. Rural residence was associated with patients’ and total delays. Providing the population with information
about TB symptoms and the importance of early health seeking may be an efficient way to decrease TB transmission,
morbidity and mortality. Establishing efficient TB diagnostic and treatment facilities at the periphery level is imperative to
reduce diagnostic delay and expedite TB treatment.
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Tuberculosis (TB) is a major public health problem in the
developing world. Over eight million new cases and 1.4
million deaths occurred as a result of TB in 2012 [1]. Glo-
bally, South East Asia and sub-Saharan African countries
have the highest TB burden. Ethiopia is one of the high* Correspondence: yimsolo@yahoo.com
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reproduction in any medium, provided the orTB burden countries in sub-Saharan Africa with an esti-
mated incidence of 258/100,000 population. According to
the 2011 Ethiopian demographic and health survey, 19.7%
of the TB patients were coinfected with HIV. The adult
HIV prevalence rate was estimated at 1.5% [2]. Prompt
diagnosis and treatment is crucial to reduce the prevalence
and incidence of TB in Ethiopia.
Delayed consultation, diagnosis and treatment of TB may
lead to severe illness among patients and TB transmission
in the community. A number of studies have been con-
ducted to investigate and determine the magnitude of fac-
tors contributing to delay in TB diagnosis and treatment. Atd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from the onset of symptoms to the start of treatment
ranged from 60 to 90 days [3]. This delay was due to re-
peated visits to the same level of health care and difficulty
in accessing better diagnostic and management services for
TB. Diagnostic and treatment delay in TB has been studied
in various regions of Ethiopia [4-8].
One of the limitations in studies addressing TB diagnos-
tic and treatment delay is linked to the nature of study
participants. Most studies only involved smear-positive
cases who are the most infectious TB patients. The exclu-
sion of extra-pulmonary (EPTB) and smear-negative TB in
delay studies limits our understanding of diagnostic delay
and the consequences of delay with regard to TB trans-
mission. Both smear-negative and EPTB patients may con-
tribute to the TB infectious pool at different levels. The
relative contribution of smear-negative cases in the trans-
mission of TB compared to smear-positive cases ranges
from 20% to 22% [9,10]. In most high TB burden coun-
tries, the proportion of smear-negative cases seen in hos-
pitals outweighs the proportion of smear-positive cases
indicating that smear-negative cases may contribute sig-
nificantly to TB transmission. The role of EPTB in the in-
fectious pool is not well documented. However, it is
common to see many EPTB patients with simultaneous
pulmonary TB (PTB). Therefore, the possibility of trans-
mission among EPTB-PTB cases may be high. One cannot
disregard the possibility of transmission among close con-
tacts of EPTB cases and the ultimate contribution of
EPTB to the TB infectious pool.
Understanding the magnitude of and factors contribut-
ing to delay in diagnosis and treatment among all cat-
egories of TB patients is crucial in designing strategies
that will improve TB control program performance. The
objective of this study was to determine the length and
analyze factors of patients’, health systems’ and total de-
lays among TB patients.
Methods
Setting
The study was conducted at the Felegehiwot Referal
Hospital in Bahir Dar city, Amhara Region, Ethiopia.
The hospital is located in the western part of the region
and serves as a referral centre for patients from neigh-
bouring zones. The majority (87.7%) of the people in
the region are rural residents and live on subsistence
farming. Food insecurity and deep-rooted poverty poses
an enormous challenge to the population in the study
area. Patients use various options to seek health care. Self-
treatment, modern health providers, traditional practi-
tioners or a combination of services may be used by
patients [4]. The first level of health care in the Ethiopian
health care delivery system is the health post. A health
post is available in each Kebele (the lowest administrativeunit with an average population of 5000) and is run by
two salaried female health extension workers who are
trained for one year in basic preventive and promotive
health services. There are no diagnostic facilities for TB at
health posts and patients must often travel long distances
to access TB diagnostic facilities in hospitals. Various
transport modalities are used to reach at the referral hos-
pital. Some patients walk on foot, or ride horse or mule.
Others may come by boat or use public transportation
that may require up to seven hours before reaching the re-
ferral hospital. Most patients in rural areas walk for up to
two hours to catch public transport that will take them to
the hospital.
Design and data collection
The study design was cross-sectional and the field work
was conducted from January to August 2010. Newly diag-
nosed PTB and EPTB cases ≥ 15 years of age were enrolled
consecutively in the study. A semi-structured questionnaire
was used to collect data including socio-demographic and
clinical factors (gender, age, education, occupation, clinical
form of TB, symptoms at presentation and HIV sero-
status). The data were collected by trained nurses and the
questionnaire was pretested before data collection was
initiated.
The national TB control guideline was followed to make
diagnoses for the different categories of TB patients [11].
Smear-positive TB is diagnosed when a patient has at least
two initial smear-positive sputum examinations for acid fast
bacilli (AFB), when AFB is detected in one of the initial
smear examinations by direct microscopy and is culture-
positive, or when one initial smear-positive examination
and radiographic findings are consistent with active TB as
determined by a clinician. Smear-negative TB is diagnosed
when a patient with symptoms suggestive of TB has at least
three initial smear-negative sputum examinations for AFB
and no response to a course of broad-spectrum antibiotics,
when a patient has three smear-negative examinations by
direct microscopy, radiological anomalies consistent with
PTB and a decision by a physician to treat with a full course
of anti-TB drugs, or when a patient’s diagnosis is based on
culture-positive Mycobacterium tuberculosis despite three
initial smear-negative examinations by direct microscopy.
EPTB is diagnosed in patients with TB in organs other than
the lungs as indicated by one culture-positive specimen
from an extra-pulmonary site or histo-pathological evi-
dence from a biopsy, or strong clinical evidence suggestive
of active EPTB and the decision by a physician to start
treatment with anti-TB chemotherapy.
Data analysis
According to the literature review that we performed,
there is no standard cutoff point to divide delay periods
into acceptable and unacceptable delays. The acceptable
Table 1 Socio-demographic and clinical characteristics of
the study participants attending Felegehiwot Referral
Hospital in Bahir Dar, Ethiopia
Variable N (%) P value
Sex
Male 124 (61,7)
Female 77 (38.3) 0.001
Age
15-34 133 (66.2)









Rural 115 (57.2) 0.41
Education
Below 8th grade 135 (67.2)
Secondary 32 (15.9)
College and above 34 (16.9) 0.000
Employment
Peasants 87 (43.3)
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thus determined by the consulting physicians and cut-off
points used in previous studies [5-8]. A cut-off point of
30 days was considered acceptable for patients’ delay. A
delay of more than 30 days was considered unacceptable
and study participants were accordingly categorized into
“delay” and “non-delay” groups. To evaluate health sys-
tems’ delay, a two week cut-off point was applied [5]; pa-
tients with delay of less than two weeks were considered
“non-delay” and those with more than two weeks were
considered “delayed”. To analyze predictor variables for
the total delay, the sample was dichotomized into “delay”
and “non-delay” taking the median total delay as a cut-
off point. Delay beyond the median total delay value was
considered unacceptable.
Data analysis was performed using Statistical Package
for the Social Sciences (SPSS) version 20 (Chicago,
Illinois). Data were presented as the number of cases and
proportions. Means and medians with interquartile range
(IQR) were calculated. Uni- and multi-variate logistic re-
gression analysis was used to evaluate the factors associ-
ated with the different delay periods. Uni-variate analysis
was performed first on each variable to calculate crude
odds ratios. Epidemiological and clinical significance of
the variables was considered for inclusion in the regres-
sion model. The goodness of fit of the multiple logistic re-
gression model was assessed using the Hosmer-Lemeshow
test. A two-sided p value of less than 0.05 was considered
statistically significant.Civil servant 20 (10.0)
Others 94 (46.8) 0.000
HIV sero-status
Positive 42 (20.9)
Negative 128 (63.7) 0.000
Not known 31 (15.4)
Patient category
Smear-positive 42 (20.9)
Smear-negative 78 (38.8) 0.000
Extra pulmonary 81 (40.3)
Income
Less than 300 birr§ 137 (68.2)
Above 300 birr 64 (31.8) 0.000
No people
1-2 49 (24.4)Definition of variables
Patients’ delay: the period from the start of TB symp-
toms until first presentation to a medical provider.
Health systems’ delay: the period from first presenta-
tion to a medical provider until first diagnosis.
Total delay: the period from start of TB symptoms
until start of treatment.
Medical providers: modern health care facilities such
as health posts, clinics, health centres or hospitals owned
by the government or the private sector.
Ethical clearance was secured from the Regional Com-
mittee for Medical Research Ethics in Eastern Norway
(REK Øst) and the Ethiopian Science and Technology
Agency in Addis Ababa, Ethiopia. All study participants
provided informed consent prior to study start.3-4 67 (33.3) 0.008
5 and above 85 (42.3)
No rooms
1 166 (82.6)
2 22 (10.9) 0.000
3 and above 13 (6.5)
§300 Birr = USD 16.Results
Characteristics of the study population
A total of 201 TB patients were included in the study; 124
(61.7%) men and 77 (38.3%) women with a mean age of 31
years. The mean age for EPTB cases (27 years) was lower
than PTB cases (33 years) (p < 0.002) (Table 1).
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Patients experienced various TB symptoms (Table 2).
Significant differences in TB symptoms were observed
between PTB and EPTB patients. Cough (73.3% PTB,
2.5% EPTB, p = 0.000), chest pain (90.8% PTB, 6.2%
EPTB, p = 0.000), and loss of appetite (95.8% PTB, 84.0%
EPTB, p = 0.004) were more common among PTB than
EPTB patients. Rheumatic pain (5.8% PTB, 58.8% EPTB,
p = 0.000) was more frequent among EPTB than PTB
patients.
Length of delay
The median time of patients’ delay was 21 days (IQR 7
days, 60 days). The median health systems’ delay was 27
days (IQR 8 days, 60 days), and the median total delay was
60 days (IQR 30 days, 121 days). One hundred thirty eight
(68.7%) of the study participants reported to medical pro-
viders less than one month after the start of symptoms.
For 132 (68.7%) of the participants, the period from first
visit to a medical provider until diagnosis took more than
two weeks. The total delay for 92 (47.8%) of the cases
exceeded two months.
Predictors of delay
Patients residing in rural areas had a three-fold increase
in patients’ delay compared to patients from urban
areas [Adjusted Odds Ratio (AOR) 3.4; 95% (CI 1.3,
9.0)]. Patients with EPTB were more likely to experience
delay in seeking treatment compared to PTB cases
[AOR 2.6; 95% (CI 1.3, 5.4)] (Table 3). HIV-positive pa-
tients were less likely to have increased health systems’
delay compared to HIV-negative patients [AOR 0.2;
95% CI (0.1, 0.5)]. Patients who first visited health cen-
tres [AOR 5.1; 95% (CI 2.1, 12.5)], private facilities
[AOR 3.5; 95% (CI 1.3, 9.7)] and health posts [AOR 109;
95% (CI 12, 950)] had longer health systems’ delay com-
pared to those who visited hospitals (Table 4). Patients
with EPTB [AOR 3.2; 95% (CI 1.5, 7.0)] and rural resi-
dents [AOR 2.8; 95% CI (1.1, 7.3)] had increased risk ofTable 2 TB symptoms experienced by TB patients attending F
Smear-positive N (%) Smear-negative
Cough 42 (100) Fever
Night sweating 41 (97.6) Night sweating
Loss of appetite 41 (97.6) Loss of appetite
Weight loss 40 (95.2) Weight loss
Fever 40 (95.2) Chest pain
Chest pain 39 (92.5) Cough
Dyspnea 38 (90.5) Dyspnea
Malaise 33 (78.6) Malaise
Haemoptysis 18 (42.9) Haemoptysis
Rheumatic pain 1 (2.4) Rheumatic paintotal delay compared to PTB cases and urban dwellers,
respectively. Patients above 55 years of age had a higher
risk of total delay compared to patients 15–34 years of
age [AOR 1.9; 95% (CI 3.3, 10.9)] (Table 5).Discussion
While the majority of the participants in this study re-
ported to medical providers within 30 days following the
onset of symptoms, diagnosis and the start of chemother-
apy was delayed. This is in accordance with the results of
some previous studies [5,6,12-14] but in contrast to other
studies that reported longer patients’ and shorter health
systems’ delays [7,15,16].
Our findings indicate that the major problem in TB
diagnosis is the amount of time used by the health system
to respond to patients’ needs. The health system needs to
be improved so that patients receive efficient health care
when they report to medical providers. Regular refresher
training courses for health extension workers and other
health care providers about the importance of recognizing
symptoms indicative of TB will help to reduce health sys-
tem delays. A rapid serological screening test for active TB
that is suitable for use at the health post will be advanta-
geous. Patients with positive rapid test results will be re-
ferred on the same day to the next level of health care for
confirmatory testing and treatment. Establishing a new
molecular method for the detection of Mycobacterium tu-
berculosis, GeneXpert, at selected health centres and refer-
ral hospitals will also serve to expedite diagnosis and
treatment of TB.
The observed median total delay is lower than the find-
ings of a former study conducted in the study area [5].
This may be related to the improved access to TB care
provided through the current health extension program in
Ethiopia. We have previously suggested the application of
“treatment delay” as an indicator of the quality of TB con-
trol program performance at the local level [17]. In this re-
gard, the lower median total delay observed in the currentelegehiwot Referral Hospital in Bahir Dar, Ethiopia
N (%) EPTB N (%)
77 (98.7) Night sweating 80 (98.8)
76 (97.4) Fever 74 (91.4)
74 (94.9) Weight loss 71 (87.7)
72 (92.3) Loss of appetite 68 (84.0)
70 (89.7) Malaise 60 (74.1)
69 (88.5) Rheumatic pain 47 (58.0)
61 (78.2) Chest pain 5 (6.2)
50 (64.1) Cough 3 (3.7)
15 (19.2)
6 (7.7)
Table 3 Associations of patient delay with socio-demographic and clinical factors among TB patients attending
Felegehiwot Referral Hospital in Bahir Dar, Ethiopia
Variable N (%) Delayed (%) Crude odds ratio 95% CI Adjusted odds ratio 95% CI
Sex
Male 124 (61,7) 40 (32.3) 1 1
Female 77 (38.3) 23 (29.9) 0.89 (0.5, 1.7) 0.5 (0.3, 1.1)
Age
15-34 133 (66.2) 39 (29.3) 1 1
35-54 53 (26.4) 17 (32.1) 1.1 (0.6, 2.3) 0.8 (0.3, 1.9)
>55 14 (7.0) 7 (50.0) 2.4 (0.8, 7.3) 2.2 (1.0, 8.5)
Marriage
Married 113 (56.2) 36 (31.9) 1 1
Single 66 (32.8) 17 (25.8) 0.7 (0.3, 1.5) 0.7 (0.3, 1.7)
Widowed 7 (3.5) 3 (42.9) 1.60 (0.3, 7.6) 3.9 (0.6, 26.2)
Divorced 15 (7.5) 7 (46.7) 1.87 (0.6, 5.6) 2.6 (0.8, 8.9)
Residence
Urban 86 (42.8) 16 (18.6) 1 1
Rural 115 (57.2) 47 (40.9) 3.02 (1.6, 5.8)* 3.4 (1.3, 8.9)*
Education
Below 8th grade 135 (67.2) 49 (36.3) 1 1
Secondary 32 (15.9) 7 (21.9) 2.20 (0.9, 5.4) 0.6 (0.2, 2.1)
College and above 34 (16.9) 7 (20.6) 1.08 (0.3, 3.5) 1.1 (0.3, 3.4)
Employment
Peasants 87 (43.3) 36 (41.4) 1 1
Civil servant 20 (10.0) 2 (10.0) 0.16 (0.0, 0.7)* 0.3 (0.0, 2.4)
Others 94 (46.8) 25 (26.6) 0.52 (0.3, 1.0) 1.3 (0.4, 3.8)
HIV serostatus
Negative 128 (63.7) 42 (32.8) 1 1
positive 42 (20.9) 12 (28.6) 0.8 (0.4, 1.8) 1.7 (0.6, 4.4)
Not known 31 (15.4) 9 (29.0) 1.8 (0.5, 1.9) 0.6 (0.2, 1.7)
Type of TB
Pulmonary 120 (59.7) 31 (25.8) 1 1
Extrapulmonary 81 (40.3) 312 (39.5) 1.86 (1.0, 3.4)* 2.6 (1.3, 5.4)*
Income
Less than 300 birr§ 137 (68.2) 47 (34.3) 1 1
Above 300 birr 64 (31.8) 16 (25.6) 0.6 (0.3, 1.2) 0.9 ( 0.4, 2.2)
§300Birr = USD 16; *significantly associated.
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local TB control program in the study area.
Patients with EPTB experienced long patients’ and total
delays compared to PTB cases. This observation is similar
with the results of other studies [3,18-22]. Most of the
EPTB patients in our study were cervical TB lymphaden-
itis cases. In rural Ethiopia, a patient with a chronic
wound, lump or mass in the neck is perceived to have
nekersa, and it is a common practice for such patients to
visit traditional healers or herbalists before reporting tomedical providers [23]. In a recent investigation con-
ducted among private practitioners in the study region,
a considerable proportion of study participants with
EPTB visited the practitioners with complications fol-
lowing treatment with herbal medications [24]. We
have also previously interviewed cervical TB lymph-
adenitis cases from the study area and observed that
some patients discontinued their anti-TB medication
and started herbal medicine (unpublished data). It is
thus likely that many of the EPTB cases might have
Table 4 Associations of health systems’ delay with sociodemographic and clinical factors among TB patients attending
Felegehiwot Referral Hospital in Bahir Dar, Ethiopia
Variable N (%) Delayed (%) Crude odds ratio 95% CI Adjusted odds ratio 95% CI
Sex
Male 124 (61,7) 84 (67.7) 1 1
Female 77 (38.3) 48 (62.3) 0.8 (0.4, 1.4) 0.8 (0.3, 1.7)
Age
15-34 133 (66.2) 87 (65.4) 1 1
35-54 53 (26.4) 34 (64.2) 0.9 (0.5, 1.8) 0.9 (0.4, 2.7)
>55 14 (7.0) 10 (71.4) 1.3 (0.4, 4.5) 0.5 (0.1, 2.7)
Marriage
Married 113 (56.2) 76 (67.3) 1 1
Single 66 (32.8) 44 (66.7) 0.9 (0.5, 1.9) 0.7 (0.2, 1.8)
Widowed 7 (3.5) 3 (42.9) 0.4 (0.1, 1.7) 0.9 (0.1, 7.7)
Divorced 15 (7.5) 9 (60.0) 2.1 (0.2, 2.2) 1.0 (0.2, 4.3)
Residence
Urban 86 (42.8) 43 (50.0) 1 1
Rural 115 (57.2) 89 (77.4) 3.4 (1.9, 6.3)* 2.2 (0.8, 6.0)
Education
Below 8th grade 135 (67.2) 94 (69.6) 1 1
Secondary 32 (15.9) 19 (59.4) 0.6 (0.3, 1.4) 1.8 (0.5, 6.4)
College and above 34 (16.9) 19 (55.9) 0.6 (0.3, 1.2) 0.8 (0.2, 2.6)
Employment
Peasants 87 (43.3) 66 (75.9) 1 1
Civil servant 20 (10.0) 10 (50.0) 0.3 (0.1, 0.9)* 1.4 (0.2, 8.0)
Others 94 (46.8) 56 (59.6) 0.5 (0.3, 0.8)* 2.2 (0.6, 7.7)
Income
Less than 300 birr§ 137 (68.2) 77 (64.2) 1 1
Above 300 birr 64 (31.8) 55 (67.9) 0.7 (0.4, 1.4) 0.9 (0.4, 2.2)
HIV serostatus
Negative 128 (63.7) 94 (73.4) 1 1
Positive 42 (20.9) 15 (35.7) 0.2 (0.1, 0.4)* 0.2 (0.1, 0.5)*
Not known 31 (15.4) 23 (74.2) 1.0 (0.4, 14.4) 0.5 (0.1, 1.4)
Type of TB
Pulmonary 120 (59.7) 93 (67.9) 1 1
Extrapulmonary 81 (40.3) 39 (60.9) 1.2 (0.7, 2.2) 0.8 (0.3, 1.7)
FHP visited
Hospital 55 (27.4) 18 (32.7) 1 1
Health centre 65 (32.3) 47 (72.3) 5.4 (2.5, 11.7)* 5.1 (2.1, 12.5)*
Private 36 (17.9) 23 (63.9) 3.6 (1.5, 8.7)* 3.5 (1.3, 9.7)*
Health post 45 (22.4) 44 (97.8) 90.4 (11.5, 710.0)* 109 (12, 958)*
§300Birr = USD 16.
*significantly associated.
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perienced delay in reporting to medical providers. Dis-
continued TB regimens among EPTB patients maylead to drug resistance. Public awareness about the im-
portance of early health seeking and the nature of
EPTB among the population needs to be improved.
Table 5 Associations of total delay with socio-demographic and clinical factors among TB patients attending
Felegehiwot Referral Hospital in Bahir Dar, Ethiopia
Variable N (%) Delayed (%) Crude Odds ratio 95% CI Adjusted odds ratio 95% CI
Sex
Male 124 (61,7) 54 (43.5) 1 1
Female 77 (38.3) 38 (49.4) 1.3 (0,7, 2.3) 0.7 (0.3, 1.5)
Age
15-34 133 (66.2) 58 (43.6) 1 1
35-54 53 (26.4) 23 (43.4) 0.9 (0.5, 1.9) 0.2 (0.2, 1.3)
>55 14 (7.0) 10 (71.4) 3.2 (0.9, 10.8) * 1.9 (3.3, 10.9) *
Marriage
Married 113 (56.2) 52 (46.0) 1 1
Single 66 (32.8) 28 (42.4) 1.6 (0.5, 1.6) 0.4 (0.2, 1.1)
Widowed 7 (3.5) 4 (57.1) 1.3 (0.3, 7.3) 15.5 (1.1, 218)
Divorced 15 (7.5) 8 (53.3) 1.3 (0.5, 3.9) 4.9 (0.9, 26.5)
Residence
Urban 86 (42.8) 22 (25.6) 1 1
Rural 115 (57.2) 70 (60.9) 4.5 (2.6, 8.4)* 2.8 (1.1, 7.3)*
Education
Below 8th grade 135 (67.2) 73 (54.1) 1 1
Secondary 32 (15.9) 12 (37.5) 0.5 (0.2, 1.1) 0.5 (0.2, 1.4)
College and above 34 (16.9) 7 (20.6) 0.2 (0.1, 0.5)* 0.5 (0.2, 1.5)
Employment
Peasants 87 (43.3) 53 (60.9) 1 1
Civil servant 20 (10.0) 4 (20.0) 0.2 (0.1, 0.5)* 0.3 (0.1, 1.7)
Others 94 (46.8) 35 (37.2) 0.4 (0.2, 0.7)* 1.5 (0.4, 5.0)
Income
Less than 300 birr§ 137 (68.2) 68 (49.6) 1 1
Above 300 birr 64 (31.8) 24 (37.5) 0.6 (0.3, 1.1) 1.1 (0.5, 2.5)
HIV serostatus
Negative 128 (63.7) 61 (47.7) 1 1
Positive 42 (20.9) 13 (31.0) 0.4 (0.2, 0.8)* 0.7 (0.3, 1.8)
Not known 31 (15.4) 18 (58.1) 0.8 (0.4, 1.9) 0.6 (0.2, 1.7)
Type of TB
Pulmonary 120 (59.7) 44 (36.7) 1 1
Extra-pulmonary 81 (40.3) 48 (59.3) 2.5 (1.4, 4.5) 3.2 (1.5, 7.0)*
FHP visited
Hospital 55 (27.4) 15 (8.2) 1 1
Health centre 65 (32.3) 30 (46.2) 1.5 (0.7, 3.2)* 1.3 (0.5, 3.1)
Private 36 (17.9) 16 (45.8) 0.9 (0.4, 2.2)* 1.1 (0.4, 3.2)
Health post 45 (22.4) 32 (71.1) 3.8 (1.5, 9.7)* 2.9 (0.9, 9.1)
§300 Birr = USD 16.
*significantly associated.
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region do not have facilities for diagnosing EPTB. The
observed increased total delay among EPTB cases may
reflect the lack of available diagnostic facilities. EPTBpatients initially receive broad spectrum antibiotics and
are referred to major towns for histopathology and other
TB examinations. This leads to a long delay before start-
ing standard TB treatment.
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and treatment start. A similar finding was observed in
other countries [25,26]. Targeted health education and
expanding diagnostic and treatment facilities for TB in
rural areas is warranted. Further qualitative research is
also needed to investigate the possible reasons for delay
among rural residents.
Patients above 55 years of age had an increased risk of
total delay that may be related to several factors. Older
patients are generally dependent on others and thus it
may be difficult for them to seek health care when
needed. TB disease may not exhibit the main symptoms
indicative of TB (i.e. cough, haemoptysis, fever, night
sweats and weight loss) in older patients. The clinical
presentation of TB in older people may be indicated by
changes in daily activity, anorexia, chronic fatigue, cog-
nitive impairment or unexplained low-grade fever [27].
TB diagnosis among this age group may thus be delayed
because of a low index of suspicion by health care pro-
viders. Health workers must consider nonspecific signs
and symptoms persisting from weeks to months that
may indicate TB among older patients.
Cough, chest pain and loss of appetite were more pro-
nounced among PTB cases than EPTB patients. This
was not surprising as the lungs are primarily involved in
PTB cases. More EPTB patients suffered from rheumatic
pain. Further studies should investigate symptoms that
are specifically associated with ETPB.
The proportion of HIV-positive individuals among those
tested was 24.7% and is higher than the national estimate
of 8% for 2011 [1]. Patients with HIV-infection experi-
enced no delay in TB diagnosis. It is possible that HIV-
positive TB patients in our study suffered more serious
symptoms indicative of TB and were thus immediately re-
ferred by the health care worker to a clinic or hospital for
testing and treatment [28]. It is also possible that health
workers have a high index of suspicion for TB when
examining persons with HIV-infection. In contrast, some
studies reported HIV as a risk factor for delay in TB diag-
nosis due to nonspecific test results and atypical clinical
features [29,30]. No association between HIV serostatus
and delayed TB diagnosis was reported in other studies
[31,32].
The World Health Organization recommends provider-
initiated HIV counselling and testing (PICT) service to all
TB patients [33]. We found a considerable number of TB
patients who had not been tested for HIV. It is important
for TB patients to know their HIV status in order to en-
sure that they will receive appropriate treatment, care and
support services for HIV [34]. This finding demonstrates
that PICT is not optimally implemented in the study site
and should be improved.
A very high proportion of patients had a family resi-
dence of only one room. The majority of familiesconstituted more than five individuals per household. TB
is a disease of poverty that commonly occurs in crowded
living conditions.
The study has several limitations. Firstly, patients were
recruited from a single governmental hospital. Similar pa-
tients who may have visited other hospitals, stayed at
home or reported to private health providers were not in-
cluded in this study. Thus it is difficult to generalize our
results to all TB patients in the study region. Secondly, pa-
tients’ memory of symptoms may be subject to recall bias.
We used the local calendar listing the main religious and
national days to estimate the date of onset of symptoms to
minimize the possibility of recall bias. Despite these con-
cerns, we believe that the study provides baseline informa-
tion about delay in diagnosis and treatment among all
categories of TB patients in a referral hospital setting.
Conclusions
In conclusion, the study demonstrated that the majority
of TB patients sought health care within an acceptable
time following the start of symptoms. Health systems’
and total delays were unacceptably high. Rural resi-
dence was associated with a longer delay in presenting
to medical providers. Patients with EPTB and those
who first visited health posts, health centres and private
facilities were more likely to experience a longer health
systems’ delay. While rural residence and crowded liv-
ing conditions cannot be changed in the near future, a
well-designed information education, communication/
behavioural change communication (IEC/BCC) strat-
egy for TB might improve the TB control program.
Health education directed towards people in rural areas
that explains how to suspect and recognize TB symp-
toms and the importance of early health seeking is
needed. Regular refresher training courses for health
extension workers and other health care providers that
address the importance of high index of suspicion for
TB may help to reduce patient and health systems fac-
tors responsible for delay. Further decentralization of
TB diagnostic and treatment facilities to the periphery
is highly recommended to reduce transmission and the
size of the TB infectious pool in the community.Competing interests
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